Disposition of 76453 shares by Gautam Patel of Amneal Pharmaceuticals subject to Rule 16b-3
AMRX Stock | USD 8.32 0.09 1.07% |
Slightly above 53% of Amneal Pharmaceuticals,'s investor base is interested to short. The analysis of overall sentiment of trading Amneal Pharmaceuticals, Class stock suggests that many investors are impartial at this time. Amneal Pharmaceuticals,'s investing sentiment can be driven by a variety of factors including economic data, Amneal Pharmaceuticals,'s earnings reports, geopolitical events, and overall market trends.
Amneal |
Filed transaction by Amneal Pharmaceuticals Class Director. Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
Read at macroaxis.com
Cash Flow Correlation
Amneal Pharmaceuticals,'s cash-flow correlation analysis can be used to evaluate the unsystematic risk during the given period. It also helps investors identify the Amneal Pharmaceuticals,'s relationships between the major components of the statement of changes in financial position and other commonly used cash-related accounts. When such correlations are discovered, they may help managers and analysts to enhance performance or determine appealing investment opportunities.Click cells to compare fundamentals
Amneal Pharmaceuticals, Investor Sentiment by Other News Outlets
Investor sentiment, mood or attitude towards Amneal Pharmaceuticals, can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Amneal Pharmaceuticals, Historical Investor Sentiment
Investor biases related to Amneal Pharmaceuticals,'s public news can be used to forecast risks associated with an investment in Amneal. The trend in average sentiment can be used to explain how an investor holding Amneal can time the market purely based on public headlines and social activities around Amneal Pharmaceuticals, Class. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Amneal Pharmaceuticals,'s market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Amneal Pharmaceuticals, and other traded tickers. The bigger the bubble, the more accurate the estimated score. Higher bars for a given day show more participation in the average Amneal Pharmaceuticals, news discussions. The higher the estimate score, the more favorable the investor's outlook on Amneal Pharmaceuticals,.
Amneal Pharmaceuticals, Fundamental Analysis
We analyze Amneal Pharmaceuticals,'s financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Amneal Pharmaceuticals, using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Amneal Pharmaceuticals, based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Current Valuation
Current Valuation Comparative Analysis
Amneal Pharmaceuticals, is currently under evaluation in current valuation category among its peers. Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Amneal Pharmaceuticals, Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Amneal Pharmaceuticals, stock to make a market-neutral strategy. Peer analysis of Amneal Pharmaceuticals, could also be used in its relative valuation, which is a method of valuing Amneal Pharmaceuticals, by comparing valuation metrics with similar companies.
Peers
Amneal Pharmaceuticals, Related Equities
PROC | Procaps Group | 94.74 | ||||
EOLS | Evolus | 3.25 | ||||
ASRT | Assertio Therapeutics | 2.11 | ||||
PAHC | Phibro Animal | 1.58 | ||||
DVAX | Dynavax Technologies | 1.56 | ||||
NBIX | Neurocrine Biosciences | 1.39 | ||||
ANIP | ANI Pharmaceuticals | 1.38 | ||||
COLL | Collegium Pharmaceutical | 1.37 | ||||
AMPH | Amphastar | 1.04 | ||||
ITCI | Intracellular | 0.22 | ||||
ALKS | Alkermes Plc | 0.75 | ||||
IRWD | Ironwood Pharmaceuticals | 5.11 | ||||
LFCR | Lifecore Biomedical | 6.68 |
Additional Tools for Amneal Stock Analysis
When running Amneal Pharmaceuticals,'s price analysis, check to measure Amneal Pharmaceuticals,'s market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Amneal Pharmaceuticals, is operating at the current time. Most of Amneal Pharmaceuticals,'s value examination focuses on studying past and present price action to predict the probability of Amneal Pharmaceuticals,'s future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Amneal Pharmaceuticals,'s price. Additionally, you may evaluate how the addition of Amneal Pharmaceuticals, to your portfolios can decrease your overall portfolio volatility.